Buckley L M, Leib E S, Cartularo K S, Vacek P M, Cooper S M
Medicial College of Virginia/Virginia Commonwealth University, Richmond 23298, USA.
J Rheumatol. 1995 Jun;22(6):1055-9.
To assess the effect of low doses of corticosteriods on the bone mineral density (BMD) of patients with rheumatoid arthritis (RA).
A cross sectional study of BMD as measured by dual photon x-ray of the femoral neck and lumbar spine (lateral view) in 139 patients with RA followed in a university setting.
The mean daily dose of prednisone taken by the study group was 4.15 mg/day. Patients receiving daily doses of prednisone between 1 to 4 mg/day had similar BMD to patients who were not receiving corticosteroids, but patients taking 5-9 mg/day and those taking > 10 mg/day had significantly lower BMD of the lumbar spine (84.28 and 80.51% of controls, respectively) than patients who received 1-4 mg/day (99.16% of controls). The effect of corticosteroids remained significant when other risk factors such as disease severity, disease duration, functional class, and activity level were controlled for. No significant relationship between prednisone dose and BMD of the femoral neck was seen at the low doses studied.
Low dose corticosteroid use has a significant effect on BMD of the lumbar spine.
评估低剂量皮质类固醇对类风湿关节炎(RA)患者骨密度(BMD)的影响。
在一所大学医疗机构中,对139例类风湿关节炎患者进行横断面研究,采用双能X线测量股骨颈和腰椎(侧位)的骨密度。
研究组患者泼尼松的平均日剂量为4.15毫克/天。每日服用泼尼松剂量在1至4毫克/天的患者,其骨密度与未接受皮质类固醇治疗的患者相似,但每日服用5至9毫克/天以及服用超过10毫克/天的患者,其腰椎骨密度(分别为对照组的84.28%和80.51%)显著低于每日服用1至4毫克/天的患者(为对照组的99.16%)。在控制疾病严重程度、病程、功能分级和活动水平等其他风险因素后,皮质类固醇的影响仍然显著。在所研究的低剂量下,未观察到泼尼松剂量与股骨颈骨密度之间存在显著关系。
低剂量使用皮质类固醇对腰椎骨密度有显著影响。